Cargando…

Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis

Bacille Calmette–Guérin (BCG) is currently the only approved vaccine against tuberculosis (TB) and is administered in over 150 countries worldwide. Despite its widespread use, the vaccine has a variable protective efficacy of 0–80%, with the lowest efficacy rates in tropical regions where TB is most...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, Dominique N., Kusewitt, Donna F., Lino, Christopher A., McBride, Amber A., Muttil, Pavan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859477/
https://www.ncbi.nlm.nih.gov/pubmed/27153120
http://dx.doi.org/10.1371/journal.ppat.1005614
_version_ 1782430968917786624
author Price, Dominique N.
Kusewitt, Donna F.
Lino, Christopher A.
McBride, Amber A.
Muttil, Pavan
author_facet Price, Dominique N.
Kusewitt, Donna F.
Lino, Christopher A.
McBride, Amber A.
Muttil, Pavan
author_sort Price, Dominique N.
collection PubMed
description Bacille Calmette–Guérin (BCG) is currently the only approved vaccine against tuberculosis (TB) and is administered in over 150 countries worldwide. Despite its widespread use, the vaccine has a variable protective efficacy of 0–80%, with the lowest efficacy rates in tropical regions where TB is most prevalent. This variability is partially due to ubiquitous environmental mycobacteria (EM) found in soil and water sources, with high EM prevalence coinciding with areas of poor vaccine efficacy. In an effort to elucidate the mechanisms underlying EM interference with BCG vaccine efficacy, we exposed mice chronically to Mycobacterium avium (M. avium), a specific EM, by two different routes, the oral and intradermal route, to mimic human exposure. After intradermal BCG immunization in mice exposed to oral M. avium, we saw a significant decrease in the pro-inflammatory cytokine IFN-γ, and an increase in T regulatory cells and the immunosuppressive cytokine IL-10 compared to naïve BCG-vaccinated animals. To circumvent the immunosuppressive effect of oral M. avium exposure, we vaccinated mice by the pulmonary route with BCG. Inhaled BCG immunization rescued IFN-γ levels and increased CD4 and CD8 T cell recruitment into airways in M. avium-presensitized mice. In contrast, intradermal BCG vaccination was ineffective at T cell recruitment into the airway. Pulmonary BCG vaccination proved protective against Mtb infection regardless of previous oral M. avium exposure, compared to intradermal BCG immunization. In conclusion, our data indicate that vaccination against TB by the pulmonary route increases BCG vaccine efficacy by avoiding the immunosuppressive interference generated by chronic oral exposure to EM. This has implications in TB-burdened countries where drug resistance is on the rise and health care options are limited due to economic considerations. A successful vaccine against TB is necessary in these areas as it is both effective and economical.
format Online
Article
Text
id pubmed-4859477
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48594772016-05-13 Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis Price, Dominique N. Kusewitt, Donna F. Lino, Christopher A. McBride, Amber A. Muttil, Pavan PLoS Pathog Research Article Bacille Calmette–Guérin (BCG) is currently the only approved vaccine against tuberculosis (TB) and is administered in over 150 countries worldwide. Despite its widespread use, the vaccine has a variable protective efficacy of 0–80%, with the lowest efficacy rates in tropical regions where TB is most prevalent. This variability is partially due to ubiquitous environmental mycobacteria (EM) found in soil and water sources, with high EM prevalence coinciding with areas of poor vaccine efficacy. In an effort to elucidate the mechanisms underlying EM interference with BCG vaccine efficacy, we exposed mice chronically to Mycobacterium avium (M. avium), a specific EM, by two different routes, the oral and intradermal route, to mimic human exposure. After intradermal BCG immunization in mice exposed to oral M. avium, we saw a significant decrease in the pro-inflammatory cytokine IFN-γ, and an increase in T regulatory cells and the immunosuppressive cytokine IL-10 compared to naïve BCG-vaccinated animals. To circumvent the immunosuppressive effect of oral M. avium exposure, we vaccinated mice by the pulmonary route with BCG. Inhaled BCG immunization rescued IFN-γ levels and increased CD4 and CD8 T cell recruitment into airways in M. avium-presensitized mice. In contrast, intradermal BCG vaccination was ineffective at T cell recruitment into the airway. Pulmonary BCG vaccination proved protective against Mtb infection regardless of previous oral M. avium exposure, compared to intradermal BCG immunization. In conclusion, our data indicate that vaccination against TB by the pulmonary route increases BCG vaccine efficacy by avoiding the immunosuppressive interference generated by chronic oral exposure to EM. This has implications in TB-burdened countries where drug resistance is on the rise and health care options are limited due to economic considerations. A successful vaccine against TB is necessary in these areas as it is both effective and economical. Public Library of Science 2016-05-06 /pmc/articles/PMC4859477/ /pubmed/27153120 http://dx.doi.org/10.1371/journal.ppat.1005614 Text en © 2016 Price et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Price, Dominique N.
Kusewitt, Donna F.
Lino, Christopher A.
McBride, Amber A.
Muttil, Pavan
Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis
title Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis
title_full Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis
title_fullStr Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis
title_full_unstemmed Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis
title_short Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis
title_sort oral tolerance to environmental mycobacteria interferes with intradermal, but not pulmonary, immunization against tuberculosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859477/
https://www.ncbi.nlm.nih.gov/pubmed/27153120
http://dx.doi.org/10.1371/journal.ppat.1005614
work_keys_str_mv AT pricedominiquen oraltolerancetoenvironmentalmycobacteriainterfereswithintradermalbutnotpulmonaryimmunizationagainsttuberculosis
AT kusewittdonnaf oraltolerancetoenvironmentalmycobacteriainterfereswithintradermalbutnotpulmonaryimmunizationagainsttuberculosis
AT linochristophera oraltolerancetoenvironmentalmycobacteriainterfereswithintradermalbutnotpulmonaryimmunizationagainsttuberculosis
AT mcbrideambera oraltolerancetoenvironmentalmycobacteriainterfereswithintradermalbutnotpulmonaryimmunizationagainsttuberculosis
AT muttilpavan oraltolerancetoenvironmentalmycobacteriainterfereswithintradermalbutnotpulmonaryimmunizationagainsttuberculosis